Mc Clarren Financial Advisors, Inc. Danaher Corp Transaction History

Mc Clarren Financial Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$235.51 - $267.98 $46,630 - $53,060	198 Added 388.24%	249 $12,000
Q1 2024 Jul 26, 2024	BUY	$224.58 - $256.19 $11,453 - $13,065	51 New	51 $13,000
Q2 2023 Aug 04, 2023	SELL	$224.99 - $256.14 $224 - $256	-1 Reduced 1.96%	50 $12,000
Q4 2022 Jan 30, 2023	BUY	$241.42 - $282.29 $241 - $282	1 Added 2.0%	51 $13,000
Q3 2022 Oct 31, 2022	BUY	$247.06 - $1507.4 $12,353 - $75,370	50 New	50 $12,000
Q2 2022 Aug 11, 2022	SELL	$237.11 - $299.66 $11,855 - $14,983	-50 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$257.27 - $315.76 $257 - $315	-1 Reduced 1.96%	50 $14,000
Q4 2021 Jan 19, 2022	BUY	$292.08 - $329.01 $292 - $329	1 Added 2.0%	51 $17,000
Q3 2021 Oct 15, 2021	BUY	$272.21 - $332.43 $13,610 - $16,621	50 New	50 $15,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Mc Clarren Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Clarren Financial Advisors, Inc. with notifications on news.